The new standard for quality, capacity, and speed in cell line development
Opto™ CLD is proven to deliver the best cell lines
Pool to Clone in Days
Replace 8-12 weeks of challenging well plate steps with Opto CLD on the Beacon optofluidic system. Screen thousands of clones in parallel with advanced in-process imaging and automation. Take a look at our webinar to learn more.
Selection based on product quality, not just productivity
The Opto CLD workflow enables selection of top clones by measuring growth over multiple days of on-chip culture and secretion titers using quantitative assays for both traditional and non- traditional antibodies. With the Opto™ Assure assay for aggregation, clones are detected and scored for aggregates with automated imaging analysis, so that those with poor quality profiles can be easily eliminated before selection and scale-up.
Capacity for up to 50 campaigns per year
Minimize operating costs and significantly reduce your CLD footprint with Opto CLD. One instrument can help you deliver up to 10 times more projects per year. Learn more in the Opto CLD brochure.
Access greater relevant cell diversity and find top rare clones with Selective Cell Cloning
Selective Cell Cloning with Opto CLD lets you screen up to 100,000 cells in a single 5-day workflow, enabling access to more relevant cell diversity than conventional methods for cell line development. Gently enrich transfected pools by identifying and cloning only cells that are viable and express your protein of interest. With Selective Cell Cloning, you can eliminate weeks of mini- pool processing by enabling deeper screening of bulk stable pools.
Find out more about how the Opto CLD workflow addresses your pain points. Just fill out the short form below and a specialist will reach out within 24 hours.